No abstract

The development of a dental gel that meets modern requirements for the effectiveness and safety of a medicinal product is a serious scientific study related to the selection of active and auxiliary substances, providing the necessary biopharmaceutical and rheological properties of the gel composition, standardizing the quality of the dosage form. The article presents the results of a study on the development of the composition and technology of the soft dosage form of the new dental gel «Matripin- Dent» using pharmacologically active ingredients of the sum of flavonoids from Populus balsamifera L. buds (pinostrobin, pinocembrin, chrysin, techtochrysin) and the sum of terpenoids from Matricaria chamomilla L. (bisabolol oxides A and B, chamazulene). Three bases are selected: fat, gel, and multicomponent. According to the results of pharmacological studies, the optimal composition is a gel base containing polyethylene oxide 1500 and 400. The rheological index of the gel base confirms its thixotropic properties, good spreadability, the ability of the obtained gel to extrude from the tube, and stability. The indicators of control and critical points of the technological process are determined and a technological scheme for the production of dental gel is developed.

В настоящей статье представлены результаты технологических исследований, направленных на создание нового нейротропного средства на основе гармина гидрохлорида. Впервые разработано пероральное лекарственное средство в форме капсул в дозе 30 мг, соответствующее фармацевтическим показателям качества.